Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Talkiatry provides virtual mental healthcare services covered by insurance, connecting patients with licensed psychiatrists.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.
Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.
Hyperfine makes MRI accessible to every patient regardless of income or resources.
TELA Bio is a life science company that specializes in soft tissue reconstruction.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
Confo Therapeutics is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
PepGen is empowering nucleic acid therapeutics to go the distance.
Perceptive Advisors has invested in 224 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Biopharma. The firm invests across 19 different industry categories.
Among tracked funding rounds, Cidara Therapeutics received $339.0M in a Grant round. Perceptive Advisors's total known invested capital is $24.4B.
Perceptive Advisors's average investment size is $125.0M across its portfolio of 224 companies.
Recent Perceptive Advisors portfolio additions include Imperative Care, Alto Neuroscience, Outlook Therapeutics, Solid Biosciences, Beam Therapeutics. These companies were founded in 2020 or later.